Bausch + Lomb (BLCO) IPO Opens Higher After Weak Pricing

Today's IPO for Bausch + Lomb Corporation (NYSE: BLCO) opened for trading at $18.50 after pricing 35,000,000 common shares at a public offering price of $18.00 per share, below the expected range.

Morgan Stanley and Goldman Sachs & Co. LLC are acting as joint lead book-running managers for the IPO. Citigroup, J.P. Morgan, Barclays, BofA Securities, Guggenheim Securities, Jefferies, Evercore ISI, Wells Fargo Securities and Deutsche Bank Securities are acting as joint book-running managers for the IPO, and DNB Markets, HSBC, Truist Securities, AmeriVet Securities, Loop Capital Markets, Ramirez & Co., Inc., R. Seelaus & Co., LLC, Siebert Williams Shank and Stern are acting as co-managers for the IPO.

Bausch + Lomb Corporation is being spun-out of Bausch Health Companies Inc. (NYSE: BHC).

Bausch + Lomb a leading global eye health business, dedicated to protecting and enhancing the gift of sight for millions of people around the world.

You May Also Be Interested In

• Holtec Nuclear Corporation files for initial public offering
• FedEx tender offers draw bids exceeding $4.15 billion cap
• Scribe Therapeutics Files for Nasdaq IPO